Cancer vaccine test results 100 percent successful-Russia claims, now it is ready for use

International news: Russia has achieved a major milestone in the fight against cancer. The Federal Medical and Biological Agency (FMBA) has announced that the country's first mRNA-based cancer vaccine 'Antromix' is ready for clinical use after successful testing. This is the same technology that was also used in several COVID-19 vaccines. mRNA vaccines induce the body's cells to produce special proteins, which activate the immune system and attack cancer cells.

Russian scientists have spent years developing the vaccine. Three years of preclinical trials have proven that the vaccine is not only safe but also remains effective after repeated doses. In some cases, cancer cells shrank, while in others, tumor growth was reduced by 60 to 80 percent.

Russia Awaits Cancer Vaccine Approval

The trials also saw significant improvements in survival rates. Scientists conducted studies on more than 48 volunteers and the final decision is now in the hands of the Russian Ministry of Health. In the coming weeks, the ministry will review the data and decide whether to approve it for public use. If approved, it would be the world's first personalized mRNA cancer vaccine.

Focused on stage one colon cancer

The first target of Enteromix will be colorectal cancer. This cancer develops in the colon or rectum and often begins as a polyp without symptoms in the early stages. Late detection of this disease makes it more deadly.

According to scientists, the next step would be to develop vaccines for glioblastoma (a fast-growing brain cancer) and some types of melanoma (skin cancer). This could change the direction of cancer treatment in the future.

A serious health crisis

Colon cancer starts in the longest part of the large intestine and plays an important role in the digestive process. This disease was mostly seen in the elderly, but now it is also increasing rapidly in young people. It is the third most common cancer worldwide and accounts for about 10 percent of all cancer cases. Colon cancer is the second leading cause of cancer deaths worldwide. Key risk factors include:

Processed Habits and New Hope

Consuming too much processed meat, lack of fruits and vegetables, sedentary lifestyle, obesity, smoking and excessive alcohol consumption are habits that multiply the chances of cancer cell growth in the body. But on the other hand, potential changes are emerging at the global level. If Entromix gets approval, it could revolutionize cancer treatment not just in Russia but worldwide. Built on mRNA technology, this vaccine promises more personalized and effective therapy. Experts believe this breakthrough could become a historic milestone in the fight against oncology.